…recombinant version, known as the Janssen COVID-19 vaccine, developed by Johnson & Johnson. The Moderna and Pfizer-BioNTech vaccines were about 95 percent effective in preventing infection with SARS-CoV-2; the Janssen vaccine was about 67 percent effective in preventing moderate to severe disease. Other vaccines included the Oxford-AstraZeneca COVID-19 vaccine, a
Read More